Division of Medical Oncology and Department of Medicine, University of Ottawa, Ottawa.
Ottawa Cancer Centre, Ottawa.
NEJM Evid. 2023 Aug;2(8):EVIDtt2300062. doi: 10.1056/EVIDtt2300062. Epub 2023 Jul 25.
Prospective Data Regarding the Optimal Frequency and ModalityProspective data regarding the optimal frequency and modality of follow up after definitive therapy for localized breast cancer is lacking, especially as it relates to time to recurrence detection. This article reviews the evidence and proposes a randomized trial to evaluate on-demand versus guideline-based survivorship care.
前瞻性数据关于局部乳腺癌根治性治疗后最佳随访频率和方式的前瞻性数据缺乏,尤其是与复发检测时间有关的前瞻性数据。本文回顾了现有证据,并提出了一项随机试验,以评估按需与基于指南的生存护理。